BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16222609)

  • 1. Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes.
    Lyons TJ
    Semin Vasc Med; 2002 May; 2(2):175-89. PubMed ID: 16222609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.
    Ceriello A
    Diabetes Nutr Metab; 1999 Feb; 12(1):42-6. PubMed ID: 10517306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: the 'metabolic memory', the new challenge of diabetes.
    Ihnat MA; Thorpe JE; Ceriello A
    Diabet Med; 2007 Jun; 24(6):582-6. PubMed ID: 17490424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis: the "metabolic memory", the new challenge of diabetes.
    Ceriello A
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S2-6. PubMed ID: 20115927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".
    Richter T; Münch G; Lüth HJ; Arendt T; Kientsch-Engel R; Stahl P; Fengler D; Kuhla B
    Neurobiol Aging; 2005 Apr; 26(4):465-74. PubMed ID: 15653175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes.
    Son SM
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S65-70. PubMed ID: 17467110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress parameters in hemodialysis patients with or without diabetes.
    Atanasiu V; Stoian I; Căpuşă C; Mircescu G; Mărăcine M; Lupescu O; Vîrgolici B; Muscurel C; Manolescu B
    Rom J Intern Med; 2006; 44(4):433-42. PubMed ID: 18386620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
    Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
    Cameron NE; Gibson TM; Nangle MR; Cotter MA
    Ann N Y Acad Sci; 2005 Jun; 1043():784-92. PubMed ID: 16037306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
    Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
    Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
    Actis Dato SM; Rebolledo OR
    Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha.
    Wu S; Ren J
    Neurosci Lett; 2006 Feb; 394(2):158-62. PubMed ID: 16260089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing cell death induced by carbonyl stress, oxidative stress or mitochondrial toxins with vitamin B anti-AGE agents.
    Mehta R; Shangari N; O'Brien PJ
    Mol Nutr Food Res; 2008 Mar; 52(3):379-85. PubMed ID: 17918169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation in health and disease: role of the modern environment.
    Vlassara H
    Ann N Y Acad Sci; 2005 Jun; 1043():452-60. PubMed ID: 16037266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on the role of fructose in the development of diabetic complications.
    Sakai M; Oimomi M; Kasuga M
    Kobe J Med Sci; 2002 Dec; 48(5-6):125-36. PubMed ID: 12594356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry to detect the site specificity of advanced glycation/lipoxidation end-product formation on protein: some challenges and solutions.
    Ames JM
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):1051-4. PubMed ID: 18793187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.